Last updated on September 2018

A Dose Response Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Methotrexate

Brief description of study

This study is a multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison study in rheumatoid arthritis participants inadequately responding to methotrexate.

Clinical Study Identifier: NCT02960438

Contact Investigators or Research Sites near you

Start Over

Customer Joy Department. EJ

Facility 1
Takarazuka, Japan